Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN45,145,17-2,88
Msft207,3207,32-1,05
Nokia3,37153,38952,55
IBM120,52120,55-0,98
Daimler AG45,6945,7-0,40
PFE36,0636,07-0,91
29.09.2020 19:11:01
Indexy online
AD Index online
select
AD Index online
 

  • 29.09.2020 16:59:38
Coloplast -B- (Copenhagen)
Poslední obchod Změna (%) Změna (DKK) Objem obchodů (DKK)
1 010,00 3,06 30,00 506 140 219
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.09.2020
Popis společnosti
Obecné informace
Název společnostiColoplast A/S
TickerCOLO B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICCOLOb.CO
ISINDK0060448595
Poslední známé roční výsledky30.09.2019
Poslední známé čtvrtletní výsledky30.06.2020
Počet zaměstnanců k 30.06.2020 12 000
Akcie v oběhu k 30.06.2020 212 714 903
Počet akcionářů k 30.09.2019 39 452
MěnaDKK
Kontaktní informace
UliceHoltedam 1-3
MěstoHUMLEBAEK
PSČ3050
ZeměDenmark
Kontatní osobaAnders Lonning-Skovgaard
Funkce kontaktní osobyChief Financial Officer, Executive Vice President, Member of the Executive Management
Telefon4 549 111 111
Fax4549111555
Kontatní telefon4 549 111 111

Business Summary: Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Financial Summary: BRIEF: For the nine months ended 30 June 2020, Coloplast A/S revenues increased 5% to DKR13.95B. Net income increased 2% to DKR3.16B. Revenues reflect Chronic Care segment increase of 7% to DKR10.84B, Wound & Skin Care segment increase of 3% to DKR1.76B, European Markets segment increase of 3% to DKR8.17B, Other Developed Markets segment increase of 7% to DKR3.43B, Emerging Markets segment increase of 7% to DKR2.35B.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Supplies
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments



  • Poslední aktualizace: 29.09.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardLars Rasmussen6005.12.2018
President, Chief Executive Officer, Member of the Executive ManagementKristian Villumsen4904.12.2018
Deputy Chairman of the BoardNiels Louis-Hansen72
Chief Financial Officer, Executive Vice President, Member of the Executive ManagementAnders Lonning-Skovgaard4701.07.201401.07.2014
Executive Vice President, Global Operations; Member of the Executive ManagementAllan Rasmussen5201.07.2014
Executive Vice President - Innovation, Member of the Executive TeamNicolai Andersen-01.10.2020
Executive Vice President, Chronic Care; Member of the Executive ManagementPaul Marcun5301.01.2015
Senior Vice President - People and Culture, Member of the Executive TeamCamilla Moehl-01.10.202001.10.2020